Brief: IPCA Labs Gets U.S. FDA Inspection Classification Of OAI For Silvassa Facility
26/11/2019 04:09
Nov 26 (Reuters) - IPCA Laboratories Ltd IPCA.NS :
* GETS COMMUNICATION FROM US FDA THAT THEY HAVE DETERMINED
INSPECTION CLASSIFICATION OF SILVASSA FACILITY AS OAI
* FDA DETERMINES FACILITY IS IN AN UNACCEPTABLE STATE OF
COMPLIANCE WITH CURRENT GOOD MANUFACTURING PRACTICE
Source text for Eikon: ID:nBSEbQVqrR
Further company coverage: IPCA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ipca Laboratories
See all newsBrief: Ipca Labs March-Quarter Consol Net Profit 3 Billion Rupees
Brief: Ipca Labs Posts Dec-Qtr Consol Net PAT 3.26 Billion Rupees
Brief: IPCA Labs Says US FDA Issues Form 483 With Three Observations
Brief: IPCA Labs Sept-Quarter Consol Net Pat 2.83 Billion Rupees
Brief: IPCA Labs Says To Sell Unit In Ankleshwar For 221.5 Mln Rupees